The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number ...

First Phase 2 chemotherapy-free, lymphodepletion-free, off-the-shelf CAR-NK cell therapy plus ANKTIVA® and rituximab regimen ...

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with NSCLC, RCC, colorectal cancer ...

Live-action adaptations of animated series can be a double-edged sword; they often face scrutiny from fans who hold the original material dear. However, the adaptation of 'Cells at Work' has managed ...

A groundbreaking phase 2 trial explores a novel, chemotherapy-free immunotherapy for relapsed indolent B-cell lymphomas, aiming to enhance patient outcomes.

A three-day retreat at Poomaale Estate, Coorg, was a masterclass in doing nothing — except forest bathing, the art of soaking in nature, not just looking.

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...

Zinc and vitamin A together can produce a synergistic effect to improve vision, immunity and other vital functions.

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

Diet and plant-derived bioactives are now recognized as active regulators of immune tone that link chronic metabolic dysfunction to cancer initiation, ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control ...

A hallmark of Parkinson's disease is the buildup of Lewy bodies—misfolded clumps of the protein known as alpha-synuclein.